{
    "organizations": [],
    "uuid": "afc2ec522b7eef627084edeb863efe36a336dc7a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-baolingbao-biologys-unit-signs-agr/brief-baolingbao-biologys-unit-signs-agreement-to-acquire-11-4-pct-stake-in-china-regenerative-medicine-idUSH9N1PE023",
    "ord_in_thread": 0,
    "title": "BRIEF-Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Baolingbao Biology Co Ltd:\n* SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN CHINA REGENERATIVE MEDICINE INTERNATIONAL, OR 11.4 PERCENT STAKE, FOR HK$360 MILLION ($46.05 million) Source text in Chinese: bit.ly/2Dze5gs Further company coverage: ($1 = 7.8170 Hong Kong dollars) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-01-25T16:30:00.000+02:00",
    "crawled": "2018-01-26T21:13:33.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "baolingbao",
        "biology",
        "co",
        "ltd",
        "say",
        "unit",
        "sign",
        "agreement",
        "buy",
        "billion",
        "share",
        "china",
        "regenerative",
        "medicine",
        "international",
        "percent",
        "stake",
        "hk",
        "million",
        "million",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "hong",
        "kong",
        "dollar",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}